University of Hong Kong-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease

    JHEP REPORTS, Vol. 4, Núm. 1